BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23087319)

  • 21. External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial.
    Goldstein DJ; Puskas JD; Alexander JH; Chang HL; Gammie JS; Marks ME; Iribarne A; Vengrenyuk Y; Raymond S; Taylor BS; Yarden O; Orion E; Dagenais F; Ailawadi G; Chu MWA; DiMaio JM; Narula J; Moquete EG; O'Sullivan K; Williams JB; Crestanello JA; Jessup M; Rose EA; Scavo V; Acker MA; Gillinov M; Mack MJ; Gelijns AC; O'Gara PT; Moskowitz AJ; Bagiella E; Voisine P
    JAMA Cardiol; 2022 Aug; 7(8):808-816. PubMed ID: 35675092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous intimal hyperplasia with occlusion of the anastomosis between saphenous vein graft and carbo-seal dacron tube after a modified Bentall procedure.
    Yu W; Wright JR; Appoo JJ
    J Heart Valve Dis; 2013 Nov; 22(6):867-71. PubMed ID: 24597412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vein graft failure: from pathophysiology to clinical outcomes.
    de Vries MR; Simons KH; Jukema JW; Braun J; Quax PH
    Nat Rev Cardiol; 2016 Aug; 13(8):451-70. PubMed ID: 27194091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath.
    Desai M; Mirzay-Razzaz J; von Delft D; Sarkar S; Hamilton G; Seifalian AM
    Vasc Med; 2010 Aug; 15(4):287-97. PubMed ID: 20511293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts.
    Rajathurai T; Rizvi SI; Lin H; Angelini GD; Newby AC; Murphy GJ
    Circ Cardiovasc Interv; 2010 Apr; 3(2):157-65. PubMed ID: 20332383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac saphenous vein bypass graft disease.
    Lau GT; Lowe HC; Kritharides L
    Semin Vasc Med; 2004 May; 4(2):153-9. PubMed ID: 15478036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tools & techniques: Percutaneous intervention of saphenous vein graft lesions.
    Agostoni P; Voskuil M; Onsea K; Vermeersch P; Stella PR
    EuroIntervention; 2011 Nov; 7(7):878-9. PubMed ID: 22082583
    [No Abstract]   [Full Text] [Related]  

  • 28. [The saphenous vein graft diseases].
    Yavuz T; Kutsal A
    Anadolu Kardiyol Derg; 2002 Mar; 2(1):50-4, AXVII. PubMed ID: 12101795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biology of saphenous vein graft occlusion: etiology and strategies for prevention.
    Bryan AJ; Angelini GD
    Curr Opin Cardiol; 1994 Nov; 9(6):641-9. PubMed ID: 7819622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saphenous vein graft disease: review of pathophysiology, prevention, and treatment.
    Kim FY; Marhefka G; Ruggiero NJ; Adams S; Whellan DJ
    Cardiol Rev; 2013; 21(2):101-9. PubMed ID: 22968180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutics of vein graft intimal hyperplasia: 100 years on.
    Wallitt EJ; Jevon M; Hornick PI
    Ann Thorac Surg; 2007 Jul; 84(1):317-23. PubMed ID: 17588453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards a Saphenous Vein Graft Moratorium.
    Motwani A; Ayinapudi K; Singh T; Maini R; Hendel R; Le Jemtel TH
    Cardiol Rev; 2020; 28(5):236-239. PubMed ID: 31985520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial versus venous bypass grafts in patients with in-stent restenosis.
    Gaudino M; Cellini C; Pragliola C; Trani C; Burzotta F; Schiavoni G; Nasso G; Possati G
    Circulation; 2005 Aug; 112(9 Suppl):I265-9. PubMed ID: 16159829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1 and vein graft occlusion in patients undergoing bypass surgery.
    Dashwood MR
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():78-87. PubMed ID: 19335750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses.
    Butany JW; David TE; Ojha M
    Can J Cardiol; 1998 May; 14(5):671-7. PubMed ID: 9627522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving coronary artery bypass graft durability: use of the external saphenous vein graft support.
    Ferrari E; von Segesser L; Berdajs D
    Multimed Man Cardiothorac Surg; 2015; 2015():. PubMed ID: 25976117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Revitalizing embolic protection in saphenous vein grafts.
    Satler LF
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):270-1. PubMed ID: 20665876
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of smooth muscle cells in coronary artery bypass grafting failure.
    Wadey K; Lopes J; Bendeck M; George S
    Cardiovasc Res; 2018 Mar; 114(4):601-610. PubMed ID: 29373656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
    Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of vein graft failure: a review.
    Davies MG; Hagen PO
    Eur J Vasc Endovasc Surg; 1995 Jan; 9(1):7-18. PubMed ID: 7664016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.